Shaanxi Meibang Pharmaceutical Group Co., Ltd. Share Price

Equities

605033

CNE100005071

Agricultural Chemicals

End-of-day quote Shanghai S.E. 03:30:00 31/05/2024 am IST 5-day change 1st Jan Change
14.72 CNY -1.80% Intraday chart for Shaanxi Meibang Pharmaceutical Group Co., Ltd. -1.21% -17.99%

Financials

Sales 2022 91Cr 13Cr 1.04TCr Sales 2023 70Cr 9.65Cr 805.2Cr Capitalization 242.68Cr 34Cr 2.8TCr
Net income 2022 14Cr 2Cr 167.02Cr Net income 2023 5.7Cr 78.72L 66Cr EV / Sales 2022 2.16 x
Net cash position 2022 40Cr 5.5Cr 458.66Cr Net cash position 2023 48Cr 6.64Cr 553.53Cr EV / Sales 2023 2.78 x
P/E ratio 2022
16 x
P/E ratio 2023
41.7 x
Employees 939
Yield 2022
1.29%
Yield 2023
0.84%
Free-Float 18.89%
More Fundamentals * Assessed data
Dynamic Chart
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Meibang Pharmaceutical Earmarks 1.4 Billion Yuan for Factory Construction MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it has received CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange Composite Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange A Share Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day-1.80%
1 week-1.21%
1 month+2.15%
3 months+8.24%
6 months-21.24%
Current year-17.99%
More quotes
1 week
14.69
Extreme 14.69
15.25
1 month
14.59
Extreme 14.59
15.80
Current year
10.30
Extreme 10.3
19.24
1 year
10.30
Extreme 10.3
19.86
3 years
10.30
Extreme 10.3
30.82
5 years
10.30
Extreme 10.3
30.82
10 years
10.30
Extreme 10.3
30.82
More quotes
Managers TitleAgeSince
Chief Executive Officer 31 10/18/10
Director of Finance/CFO 57 10/18/10
Chairman 38 -
Members of the board TitleAgeSince
Chairman 54 10/18/10
Director/Board Member 57 -
Chief Executive Officer 31 10/18/10
More insiders
Date Price Change Volume
31/24/31 14.72 -1.80% 743,500
30/24/30 14.99 +0.13% 762,100
29/24/29 14.97 +1.08% 608,923
28/24/28 14.81 -1.79% 515,523
27/24/27 15.08 +1.21% 652,323

End-of-day quote Shanghai S.E., May 31, 2024

More quotes
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
More about the company
  1. Stock Market
  2. Equities
  3. 605033 Stock